Dulaglutide Dosage Guide
95/100 confidenceComplete guide to Dulaglutide dosing protocols, administration methods, and safety considerations for research purposes.
NOT Medical Advice
The dosage and calculator information provided is for educational and research purposes only. Peptides are not approved by the FDA for human use. Individual responses vary significantly. Always consult with a qualified healthcare professional before making any decisions related to peptide research or use.
Detailed Dosage Information
Start at 0.75mg once weekly, may increase to 1.5mg, 3mg, or maximum 4.5mg weekly based on glycemic response.
Administration Method
Subcutaneous injection once weekly, any time of day, with or without food. Comes in pre-filled single-dose pens.
Research Backing
Extensive Phase 3 AWARD/REWIND trials, cardiovascular outcome studies, and full FDA prescribing information; decades of equivalent GLP-1 class data.
Side Effects to Monitor
Nausea, diarrhea, vomiting, abdominal pain, decreased appetite. Generally well-tolerated with gradual dose titration.
Safety Considerations & Risks
Same class warnings: thyroid tumors, pancreatitis, diabetic retinopathy complications. Avoid in severe GI disease.